Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / CL A
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
5,748,021
-
Shares change
-
+180,860
-
Total reported value, excl. options
-
$125,472,003
-
Value change
-
+$3,908,026
-
Number of buys
-
34
-
Number of sells
-
-9
-
Price
-
$21.83
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2016
53 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2016.
REATA PHARMACEUTICALS INC - CL A (RETA) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,748,021 shares
.
Largest 10 shareholders include Novo A/S (3,367,763 shares), EMERALD ADVISERS INC/PA (327,147 shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (250,000 shares), EMERALD MUTUAL FUND ADVISERS TRUST (229,559 shares), BlackRock Fund Advisors (183,797 shares), FMR LLC (169,006 shares), JPMORGAN CHASE & CO (145,093 shares), VANGUARD GROUP INC (142,880 shares), BlackRock Institutional Trust Company, N.A. (129,657 shares), and STATE STREET CORP (100,414 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.